It is important to note that candidalysin can indirectly activate the epidermal growth factor receptor (EGFR), a complex mechanism involving EGFR and matrix metalloproteinase (MMP) ligands, which are involved in many types of cancer [56]. The gene discussed is EGFR; the disease is cancer.